Erratum: Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth (J Clin Invest. (2021) 131: 10 (e146777) DOI: 10.1172/JCI146777)

Michael D. Nyquist, Lisa S. Ang, Alexandra Corella, Ilsa M. Coleman, Michael P. Meers, Anthony J. Christiani, Cordell Pierce, Derek H. Janssens, Hannah E. Meade, Arnab Bose, Lauren Brady, Timothy Howard, Navonil de Sarkar, Sander B. Frank, Ruth F. Dumpit, James T. Dalton, Eva Corey, Stephen R. Plymate, Michael C. Haffner, Elahe A. MostaghelPeter S. Nelson

Research output: Contribution to journalComment/debate

Abstract

The heatmap shown in Figure 2A was incorrect. The correct figure part is below. The manuscript has been corrected online. The authors regret the error.

Original languageEnglish
Article numbere151719
JournalJournal of Clinical Investigation
Volume131
Issue number12
DOIs
StatePublished - Jun 2021

Fingerprint

Dive into the research topics of 'Erratum: Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth (J Clin Invest. (2021) 131: 10 (e146777) DOI: 10.1172/JCI146777)'. Together they form a unique fingerprint.

Cite this